Featured Products

2025 State Performance & Best Practices for the Prevention and Reduction of Underage Drinking - SAMHSA

2025 State Performance & Best Practices for the Prevention and Reduction of Underage Drinking - SAMHSA

SKU 45460
$0.00
Buy Now
Suicide Prevention Month 2026 Faith Toolkit - SAMHSA

Suicide Prevention Month 2026 Faith Toolkit - SAMHSA

SKU 45458
$0.00
Buy Now
A Step-By-Step Guide to Self-Exclude from Gambling Websites and Gambling Smart Phone Apps -TGC

A Step-By-Step Guide to Self-Exclude from Gambling Websites and Gambling Smart Phone Apps -TGC

SKU 45451
$0.00
Buy Now
ONDCP DRUG THREAT NOTICE: Cyclorphine

ONDCP DRUG THREAT NOTICE: Cyclorphine

SKU 45453
$0.00
Buy Now
0

MAT

Store / MAT

Medication-assisted treatment (MAT) is the use of medications, in combination with counseling and behavioral therapies, to provide a “whole-patient” approach to the treatment of substance use disorders. Medications used in MAT are approved by the Food and Drug Administration (FDA) and MAT programs are clinically driven and tailored to meet each patient’s needs.

Filters

Clear all
Filters
Clear all
Adult Drug Courts and Medication-Assisted Treatment for Opioid Dependence
Adult Drug Courts and Medication-Assisted Treatment for Opioid Dependence
Adult Drug Courts and Medication-Assisted Treatment for Opioid Dependence
$0.00
Clinical Use of Extended-Release Injectable Naltrexone in the Treatment of Opioid Use Disorder: A Brief Guide
Clinical Use of Extended-Release Injectable Naltrexone in the Treatment of Opioid Use Disorder: A Brief Guide
Clinical Use of Extended-Release Injectable Naltrexone in the Treatment of Opioid Use Disorder: A Brief Guide
$0.00
Use of Medication-Assisted Treatment in Emergency Departments
Use of Medication-Assisted Treatment in Emergency Departments
Use of Medication-Assisted Treatment in Emergency Departments
$0.00
Use of Medication-Assisted Treatment for Opioid Use Disorder in Criminal Justice Settings
Use of Medication-Assisted Treatment for Opioid Use Disorder in Criminal Justice Settings
Use of Medication-Assisted Treatment for Opioid Use Disorder in Criminal Justice Settings
$0.00
MAT Inside Correctional Facilities: Addressing Medication Diversion
MAT Inside Correctional Facilities: Addressing Medication Diversion
MAT Inside Correctional Facilities: Addressing Medication Diversion
$0.00
Decisions in Recovery: Treatment for Opioid Use Disorders
Decisions in Recovery: Treatment for Opioid Use Disorders
Decisions in Recovery: Treatment for Opioid Use Disorders
$0.00
A Collaborative Approach to the Treatment of Pregnant Women with Opioid Use Disorders
A Collaborative Approach to the Treatment of Pregnant Women with Opioid Use Disorders
A Collaborative Approach to the Treatment of Pregnant Women with Opioid Use Disorders
$0.00
Advisory: Sublingual and Transmucosal Buprenorphine for Opioid Use Disorder: Review and Update
Advisory: Sublingual and Transmucosal Buprenorphine for Opioid Use Disorder: Review and Update
Advisory: Sublingual and Transmucosal Buprenorphine for Opioid Use Disorder: Review and Update
$0.00
Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs Based on TIP 43
Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs Based on TIP 43
Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs Based on TIP 43
$0.00
La crisis de los opioides en la po The Opioid Crisis and the Hispanic/Latino Population: An Urgent Issue Spanish - The Opioid Crisis and the Hispanic/Latino Population: An Urgent Issue
La crisis de los opioides en la po The Opioid Crisis and the Hispanic/Latino Population: An Urgent Issue Spanish - The Opioid Crisis and the Hispanic/Latino Population: An Urgent Issue
La crisis de los opioides en la po The Opioid Crisis and the Hispanic/Latino Population: An Urgent Issue Spanish - The Opioid Crisis and the Hispanic/Latino Population: An Urgent Issue
$0.00
The Opioid Crisis and the Hispanic/Latino Population: An Urgent Issue
The Opioid Crisis and the Hispanic/Latino Population: An Urgent Issue
The Opioid Crisis and the Hispanic/Latino Population: An Urgent Issue
$0.00
Practical Tools for Prescribing and Promoting Buprenorphine in Primary Care Settings
Practical Tools for Prescribing and Promoting Buprenorphine in Primary Care Settings
Practical Tools for Prescribing and Promoting Buprenorphine in Primary Care Settings
$0.00
Talk. They Hear You. Talking with Your Teen About Opioids: Keeping Your Kids Safe – Parent Brochure
Talk. They Hear You. Talking with Your Teen About Opioids: Keeping Your Kids Safe – Parent Brochure
Talk. They Hear You. Talking with Your Teen About Opioids: Keeping Your Kids Safe – Parent Brochure
$0.00
TIP 63: Medications for Opioid Use Disorder - Full Document
TIP 63: Medications for Opioid Use Disorder - Full Document
TIP 63: Medications for Opioid Use Disorder - Full Document
$0.00
Opioid Facts for Teens
Opioid Facts for Teens
Opioid Facts for Teens
$0.00
Telehealth for the Treatment of Serious Mental Illness and Substance Use Disorders
Telehealth for the Treatment of Serious Mental Illness and Substance Use Disorders
Telehealth for the Treatment of Serious Mental Illness and Substance Use Disorders
$0.00
COMPREHENSIVE CASE MANAGEMENT FOR SUBSTANCE USE DISORDER TREATMENT
COMPREHENSIVE CASE MANAGEMENT FOR SUBSTANCE USE DISORDER TREATMENT
COMPREHENSIVE CASE MANAGEMENT FOR SUBSTANCE USE DISORDER TREATMENT
$0.00
USING MOTIVATIONAL INTERVIEWING IN SUBSTANCE USE DISORDER TREATMENT
USING MOTIVATIONAL INTERVIEWING IN SUBSTANCE USE DISORDER TREATMENT
USING MOTIVATIONAL INTERVIEWING IN SUBSTANCE USE DISORDER TREATMENT
$0.00
Federal Guidelines for Opioid Treatment Programs
Federal Guidelines for Opioid Treatment Programs
Federal Guidelines for Opioid Treatment Programs
$0.00
Opioid Crisis Training
Opioid Crisis Training
Opioid Crisis Training
$0.00
What is Telemental Health?
What is Telemental Health?
What is Telemental Health?
$0.00
TN REDLINE Flyer
TN REDLINE Flyer
TN REDLINE Flyer
$0.00
Preventing Opioid Misuse and Treating Opioid Use Disorders in Older Adults
Preventing Opioid Misuse and Treating Opioid Use Disorders in Older Adults
Preventing Opioid Misuse and Treating Opioid Use Disorders in Older Adults
$0.00
The Truth About Heroin Booklet
The Truth About Heroin Booklet
The Truth About Heroin Booklet
$0.00
The Truth About Painkillers Booklet
The Truth About Painkillers Booklet
The Truth About Painkillers Booklet
$0.00
Tennessee Redline Cards
Tennessee Redline Cards
Tennessee Redline Cards
$0.00
Community Opioid Overdose Reversal Medications (OORMs) Planning Toolkit
Community Opioid Overdose Reversal Medications (OORMs) Planning Toolkit
Community Opioid Overdose Reversal Medications (OORMs) Planning Toolkit
$0.00
Decisions in Recovery: Treatment for Opioid Use Disorders
Decisions in Recovery: Treatment for Opioid Use Disorders
Decisions in Recovery: Treatment for Opioid Use Disorders
$0.00
Xylazine and Drug Mixtures
Xylazine and Drug Mixtures
Xylazine and Drug Mixtures
$0.00
Behavioral Health among Older Adults: Results from National Surveys on Drug Use and Health
Behavioral Health among Older Adults: Results from National Surveys on Drug Use and Health
Behavioral Health among Older Adults: Results from National Surveys on Drug Use and Health
$0.00
The Truth About Fentanyl Booklet
The Truth About Fentanyl Booklet
The Truth About Fentanyl Booklet
$0.00
Naloxone Drug Facts
Naloxone Drug Facts
Naloxone Drug Facts
$0.00
The Facts about Buprenorphine for Treatment of Opioid Addiction
The Facts about Buprenorphine for Treatment of Opioid Addiction
The Facts about Buprenorphine for Treatment of Opioid Addiction
$0.00
Use of High Dose Buprenorphine for the Treatment of Opioid Use Disorder
Use of High Dose Buprenorphine for the Treatment of Opioid Use Disorder
Use of High Dose Buprenorphine for the Treatment of Opioid Use Disorder
$0.00
Evidence-Based Strategies for Preventing Opioid Overdose
Evidence-Based Strategies for Preventing Opioid Overdose
Evidence-Based Strategies for Preventing Opioid Overdose
$0.00
Advisory: Expanding Access to Methadone Treatment in Hospital Settings
Advisory: Expanding Access to Methadone Treatment in Hospital Settings
Advisory: Expanding Access to Methadone Treatment in Hospital Settings
$0.00
Guidelines for Implementing Medications for Opioid Use Disorder Treatment in State Prisons
Guidelines for Implementing Medications for Opioid Use Disorder Treatment in State Prisons
Guidelines for Implementing Medications for Opioid Use Disorder Treatment in State Prisons
$0.00
Naloxone Saturation Policy Academy Retrospective Report
Naloxone Saturation Policy Academy Retrospective Report
Naloxone Saturation Policy Academy Retrospective Report
$0.00
Advisory: Clinical Considerations for Methadone Treatment of Opioid Use Disorder in Correctional Facilities
Advisory: Clinical Considerations for Methadone Treatment of Opioid Use Disorder in Correctional Facilities
Advisory: Clinical Considerations for Methadone Treatment of Opioid Use Disorder in Correctional Facilities
$0.00
Opioid Use During Pregnancy
Opioid Use During Pregnancy
Opioid Use During Pregnancy
$0.00
Opioid Rapid Response Program
Opioid Rapid Response Program
Opioid Rapid Response Program
$0.00
Preventing Opioid Use Disorder
Preventing Opioid Use Disorder
Preventing Opioid Use Disorder
$0.00
Stigma Reduction: The Effects of Stigma on Substance Use Disorder
Stigma Reduction: The Effects of Stigma on Substance Use Disorder
Stigma Reduction: The Effects of Stigma on Substance Use Disorder
$0.00
TIP 63: Medications for Opioid Use Disorder Executive Summary
TIP 63: Medications for Opioid Use Disorder Executive Summary
TIP 63: Medications for Opioid Use Disorder Executive Summary
$0.00
Naltrexone - (NAMI)
Naltrexone - (NAMI)
Naltrexone - (NAMI)
$0.00
Ibogaine
Ibogaine
Ibogaine
$0.00
Ibogaine: Myth Vs. Fact
Ibogaine: Myth Vs. Fact
Ibogaine: Myth Vs. Fact
$0.00
Psychedelic Therapy: A Primer for Primary Care Clinicians— Ibogaine
Psychedelic Therapy: A Primer for Primary Care Clinicians— Ibogaine
Psychedelic Therapy: A Primer for Primary Care Clinicians— Ibogaine
$0.00
What is Naltrexone - SAMHSA
What is Naltrexone - SAMHSA
What is Naltrexone - SAMHSA
$0.00
Expanding Access to Medications for Opioid Use Disorder: The Role of Pharamacists and the Settings in Which They Work - SAMHSA
Expanding Access to Medications for Opioid Use Disorder: The Role of Pharamacists and the Settings in Which They Work - SAMHSA
Expanding Access to Medications for Opioid Use Disorder: The Role of Pharamacists and the Settings in Which They Work - SAMHSA
$0.00
Display prices in: USD